Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Insight, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

"Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Insight, 2019" report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Chronic Kidney Disease (Chronic Renal Failure) development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

The report assesses the active Chronic Kidney Disease (Chronic Renal Failure) pipeline products by developmental stage, product type, molecule type, and administration route.

Key Topics Covered:

1. Report Introduction

2. Chronic Kidney Disease (Chronic Renal Failure) Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Chronic Kidney Disease (Chronic Renal Failure)

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Mentioned (Partial List)

  • Angion Biomedica Corp.
  • Astellas Pharma
  • BioAegis Therapeutics Inc.
  • Boehringer Ingelheim
  • Celgene Corporation
  • Cellmid Ltd.
  • CTI BioPharma
  • Eli Lilly
  • Gilead Sciences
  • Hoffmann-La Roche
  • La Jolla Pharmaceutical Company

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/qh9r6q/chronic_kidney?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Liver and Kidney Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Liver and Kidney Disorders Drugs